Letrozole in Patients With Hepatopulmonary Syndrome
Summary
- Eligibility
- for people ages 18-99 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Yvonne Kelly, MD
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Yvonne Kelly, MD
Nightfloat Physician, Surgery, School of Medicine. Authored (or co-authored) 14 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Mayo Clinic
- Links
- Mayo Clinic Clinical Trials
- ID
- NCT04577001
- Phase
- Phase 2 Hepatopulmonary Syndrome Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated